Does the media prefer BSX or ALGN?

In the previous week, Boston Scientific had 14 more articles in the media than Align Technology. MarketBeat recorded 24 mentions for Boston Scientific and 10 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.03 beat Align Technology's score of 0.76 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 14 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BSX or HQY?

In the previous week, Boston Scientific had 16 more articles in the media than HealthEquity. MarketBeat recorded 24 mentions for Boston Scientific and 8 mentions for HealthEquity. Boston Scientific's average media sentiment score of 1.03 beat HealthEquity's score of 0.74 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 14 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MMSI or BSX?

In the previous week, Boston Scientific had 22 more articles in the media than Merit Medical Systems. MarketBeat recorded 24 mentions for Boston Scientific and 2 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.03 beat Merit Medical Systems' score of 0.94 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 14 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or BSX?

In the previous week, Boston Scientific had 11 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Boston Scientific and 13 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.03 beat AMN Healthcare Services' score of 0.60 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 14 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, DVA or BSX?

Boston Scientific has higher revenue and earnings than DaVita. Boston Scientific is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 1.09 $746.80M $10.78 21.57 Boston Scientific $20.07B 3.31 $2.90B $2.39 18.69

Is DVA or BSX more profitable?

Boston Scientific has a net margin of 17.29% compared to DaVita's net margin of 5.65%. Boston Scientific's return on equity of 19.17% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets DaVita 5.65% -270.37% 4.87% Boston Scientific 17.29% 19.17% 10.77%

Does the media prefer DVA or BSX?

In the previous week, Boston Scientific had 17 more articles in the media than DaVita. MarketBeat recorded 24 mentions for Boston Scientific and 7 mentions for DaVita. Boston Scientific's average media sentiment score of 1.03 beat DaVita's score of 0.56 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 14 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Boston Scientific (BSX) Competitors

$44.67 -0.32 (-0.70%)

Closing price 07/10/2026 03:59 PM Eastern

Extended Trading

$44.99 +0.32 (+0.71%)

As of 07/10/2026 07:59 PM Eastern

Compare

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

Should you buy Boston Scientific stock or one of its competitors? MarketBeat compares Boston Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Boston Scientific include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and DaVita (DVA). These companies are all part of the "medical" sector.

How does Boston Scientific compare to Align Technology?

Boston Scientific (NYSE:BSX) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Boston Scientific had 14 more articles in the media than Align Technology. MarketBeat recorded 24 mentions for Boston Scientific and 10 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.03 beat Align Technology's score of 0.76 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	14 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69
Align Technology	$4.03B	3.19	$410.35M	$5.96	30.11

Boston Scientific presently has a consensus price target of $81.32, indicating a potential upside of 82.03%. Align Technology has a consensus price target of $206.07, indicating a potential upside of 14.84%. Given Boston Scientific's higher possible upside, equities analysts clearly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.80

Boston Scientific has a net margin of 17.29% compared to Align Technology's net margin of 10.50%. Boston Scientific's return on equity of 19.17% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Align Technology	10.50%	15.82%	10.17%

Boston Scientific has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Summary

Boston Scientific beats Align Technology on 11 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

Boston Scientific (NYSE:BSX) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Boston Scientific has a net margin of 17.29% compared to HealthEquity's net margin of 17.25%. Boston Scientific's return on equity of 19.17% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
HealthEquity	17.25%	14.75%	9.22%

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69
HealthEquity	$1.31B	6.01	$215.20M	$2.67	35.36

Boston Scientific has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

In the previous week, Boston Scientific had 16 more articles in the media than HealthEquity. MarketBeat recorded 24 mentions for Boston Scientific and 8 mentions for HealthEquity. Boston Scientific's average media sentiment score of 1.03 beat HealthEquity's score of 0.74 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	14 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific presently has a consensus price target of $81.32, suggesting a potential upside of 82.03%. HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 17.13%. Given Boston Scientific's higher possible upside, analysts plainly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

Summary

Boston Scientific beats HealthEquity on 11 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Boston Scientific has a net margin of 17.29% compared to Merit Medical Systems' net margin of 9.03%. Boston Scientific's return on equity of 19.17% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Boston Scientific	17.29%	19.17%	10.77%

Merit Medical Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

In the previous week, Boston Scientific had 22 more articles in the media than Merit Medical Systems. MarketBeat recorded 24 mentions for Boston Scientific and 2 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.03 beat Merit Medical Systems' score of 0.94 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	14 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.89	$128.49M	$2.31	31.79
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69

Merit Medical Systems currently has a consensus price target of $92.80, indicating a potential upside of 26.36%. Boston Scientific has a consensus price target of $81.32, indicating a potential upside of 82.03%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77

Summary

Boston Scientific beats Merit Medical Systems on 14 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

AMN Healthcare Services presently has a consensus price target of $27.00, indicating a potential downside of 16.82%. Boston Scientific has a consensus price target of $81.32, indicating a potential upside of 82.03%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.46	-$95.70M	-$0.87	N/A
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69

AMN Healthcare Services has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Boston Scientific has a net margin of 17.29% compared to AMN Healthcare Services' net margin of -0.95%. Boston Scientific's return on equity of 19.17% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Boston Scientific	17.29%	19.17%	10.77%

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Boston Scientific had 11 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Boston Scientific and 13 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.03 beat AMN Healthcare Services' score of 0.60 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	14 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Boston Scientific beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to DaVita?

DaVita (NYSE:DVA) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Boston Scientific has higher revenue and earnings than DaVita. Boston Scientific is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	1.09	$746.80M	$10.78	21.57
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69

Boston Scientific has a net margin of 17.29% compared to DaVita's net margin of 5.65%. Boston Scientific's return on equity of 19.17% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	5.65%	-270.37%	4.87%
Boston Scientific	17.29%	19.17%	10.77%

In the previous week, Boston Scientific had 17 more articles in the media than DaVita. MarketBeat recorded 24 mentions for Boston Scientific and 7 mentions for DaVita. Boston Scientific's average media sentiment score of 1.03 beat DaVita's score of 0.56 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	14 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

DaVita has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

90.1% of DaVita shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.5% of DaVita shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DaVita presently has a consensus price target of $209.00, indicating a potential downside of 10.11%. Boston Scientific has a consensus price target of $81.32, indicating a potential upside of 82.03%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77

Summary

Boston Scientific beats DaVita on 12 of the 17 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$66.87B	$8.80B	$7.12B	$23.43B
Dividend Yield	N/A	2.52%	2.68%	4.04%
P/E Ratio	18.69	16.12	27.22	31.27
Price / Sales	3.31	7.15	590.16	20.39
Price / Cash	11.15	18.15	49.34	25.05
Price / Book	2.71	3.60	10.90	4.77
Net Income	$2.90B	$228.19M	$3.57B	$1.07B
7 Day Performance	-0.92%	-0.18%	-0.25%	-0.50%
1 Month Performance	-5.38%	-0.41%	5.77%	2.09%
1 Year Performance	-56.70%	-5.19%	28.14%	16.03%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.9914 of 5 stars	$44.67 -0.7%	$81.32 +82.0%	-57.0%	$66.87B	$20.07B	18.69	59,000	Positive News Analyst Downgrade
ALGN Align Technology	4.0276 of 5 stars	$173.43 -2.8%	$205.85 +18.7%	-12.2%	$12.42B	$4.03B	29.10	20,290	News Coverage Analyst Upgrade
HQY HealthEquity	4.123 of 5 stars	$87.81 -0.7%	$110.57 +25.9%	-2.9%	$7.34B	$1.34B	32.89	2,814	Insider Trade
MMSI Merit Medical Systems	4.3276 of 5 stars	$70.09 -2.3%	$92.80 +32.4%	-22.8%	$4.18B	$1.54B	30.34	7,500	Positive News Analyst Forecast
AMN AMN Healthcare Services	1.9699 of 5 stars	$32.55 -0.6%	$27.00 -17.1%	+47.0%	$1.26B	$2.73B	N/A	2,664	Positive News Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to DaVita?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

How does Boston Scientific compare to Align Technology?

Do insiders and institutionals believe in BSX or ALGN?

Does the media prefer BSX or ALGN?

Which has better valuation & earnings, BSX or ALGN?

Do analysts prefer BSX or ALGN?

Is BSX or ALGN more profitable?

Which has more volatility and risk, BSX or ALGN?

Summary

How does Boston Scientific compare to HealthEquity?

Do insiders & institutionals hold more shares of BSX or HQY?

Is BSX or HQY more profitable?

Which has better valuation & earnings, BSX or HQY?

Which has more risk & volatility, BSX or HQY?

Does the media refer more to BSX or HQY?

Do analysts prefer BSX or HQY?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Is MMSI or BSX more profitable?

Which has more volatility and risk, MMSI or BSX?

Does the media refer more to MMSI or BSX?

Do institutionals and insiders have more ownership in MMSI or BSX?

Which has stronger earnings and valuation, MMSI or BSX?

Do analysts recommend MMSI or BSX?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Do analysts recommend AMN or BSX?

Which has stronger valuation & earnings, AMN or BSX?

Which has more risk and volatility, AMN or BSX?

Is AMN or BSX more profitable?

Do insiders & institutionals have more ownership in AMN or BSX?

Does the media prefer AMN or BSX?

Summary

How does Boston Scientific compare to DaVita?

Which has stronger valuation & earnings, DVA or BSX?

Is DVA or BSX more profitable?

Does the media prefer DVA or BSX?

Which has more risk and volatility, DVA or BSX?

Do insiders & institutionals have more ownership in DVA or BSX?

Do analysts recommend DVA or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools